As of October 2023 Novozymes has a market cap of $10.83 Billion. This makes Novozymes the world's 1382th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $10.83 B | -22.21% |
2022 | $13.93 B | -38.5% |
2021 | $22.65 B | 40.63% |
2020 | $16.10 B | 17.14% |
2019 | $13.75 B | 7.29% |
2018 | $12.81 B | -23.05% |
2017 | $16.65 B | 58.49% |
2016 | $10.50 B | -28.47% |
2015 | $14.69 B | 12.37% |
2014 | $13.07 B | -1.78% |
2013 | $13.31 B | 51.08% |
2012 | $8.81 B | -9.4% |
2011 | $9.72 B | 11.46% |
2010 | $8.72 B | 34.97% |
2009 | $6.46 B | |
2007 | $7.03 B | 27.88% |
2006 | $5.49 B |
On Oct 2nd, 2023 the market cap of Novozymes was reported to be: